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ABSTRACT
Purpose: The patients diagnosed with Ehlers–Danlos Syndrome Hypermobility Type (EDS-HT) are charac-
terized by pain, proprioceptive inacuity, muscle weakness, potentially leading to activity limitations. In
EDS-HT, a direct relationship between muscle strength, proprioception and activity limitations has never
been studied. The objective of the study was to establish the association between muscle strength and
activity limitations and the impact of proprioception on this association in EDS-HT patients.
Methods: Twenty-four EDS-HT patients were compared with 24 controls. Activity limitations were quanti-
fied by Health Assessment Questionnaire (HAQ), Six-Minute Walk test (6MWT) and 30-s chair-rise test
(30CRT). Muscle strength was quantified by handheld dynamometry. Proprioception was quantified by
movement detection paradigm. In analyses, the association between muscle strength and activity limita-
tions was controlled for proprioception and confounders.
Results: Muscle strength was associated with 30CRT (r¼ 0.67, p¼<0.001), 6MWT (r¼ 0.58, p¼<0.001)
and HAQ (r¼ 0.63, p¼<0.001). Proprioception was associated with 30CRT (r¼ 0.55, p< 0.001), 6MWT
(r¼ 0.40, p¼<0.05) and HAQ (r¼ 0.46, p< 0.05). Muscle strength was found to be associated with activity
limitations, however, proprioceptive inacuity confounded this association.
Conclusions: Muscle strength is associated with activity limitations in EDS-HT patients. Joint propriocep-
tion is of influence on this association and should be considered in the development of new treatment
strategies for patients with EDS-HT.
 IMPLICATIONS FOR REHABILITATION
 Reducing activity limitations by enhancing muscle strength is frequently applied in the treatment of
EDS-HT patients. Although evidence regarding treatment efficacy is scarce, the current paper confirms
the rationality that muscle strength is an important factor in the occurrence of activity limitations in
EDS-HT patients.
 Although muscle strength is the most dominant factor that is associated with activity limitations, this
association is confounded by proprioception. In contrast to common belief proprioception was not
directly associated with activity limitations but confounded this association. Controlling muscle
strength on the bases of proprioceptive input may be more important for reducing activity limitations
than just enhancing sheer muscle strength.
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Introduction
Patients diagnosed with Ehlers–Danlos syndrome, are character-
ized by an altered structural integrity of connective tissue [1,2]
resulting in frailty [3] and multi-systemic manifestations like ortho-
static intolerance,[4] hyper-elastic skin,[5] organ dysfunction [6]
and joint instability.[7] The phenotype of EDS-HT is heteroge-
neous, in which the severity of complaints varies from mild to
severe.[5,8] Despite of this, a specific clinical pattern is present on
which the diagnosis is established.[8] Clinical diagnosis of EDS-HT
is based on the Villefranche criteria, a validated set of clinical fea-
tures, that are specific to EDS-HT, in which the presence of
Generalized Joint Hypermobility (GJH), hyper-elastic skin, pain,
form the mainstay of diagnostic criteria.[8–10]
Pain and fatigue are highly prevalent in EDS-HT patients. Pain
is present in multiple joints over a period of>3 months is one of
the diagnostic criteria.[9] Pain has several causes and can appear
by minimal provocation and is frequently the result of biomechan-
ical overload. Pain and fatigue,[10,11] combined with multi-sys-
temic dysfunction, may cause severe limitations in daily activities.
[12,13] EDS-HT patients often perceive limitations during (stair)
walking, self-care, transfers, sports and household activities.[12] In
addition, these individuals show an higher dependency on assist-
ive devices.[14] The underlying mechanisms of the musculoskel-
etal complaints and functional decline remain unknown.[15]
In EDS-HT patients, an important aim of rehabilitation is to
reduce activity limitations by increasing muscle strength and
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enhancing motor control. However, the evidence to support this
rationality is scarce.[10,15–17] When developing effective treatment
it is essential to know which factors are associated with activity lim-
itations. Muscle strength might be an important determinant of
activity limitations, however, a direct relationship between muscle
strength and activity limitations in EDS-HT has never been demon-
strated. Muscle weakness and atrophy have frequently been
observed in both non-symptomatic [18] (e.g. dancers) and symp-
tomatic forms of GJH (e.g. EDS-HT, hypermobility syndrome) [19–
21] In these studies, muscle weakness was found to be associated
with pain [22] and fatigue.[21] However, whether these factors
moderate the association between muscle strength and activity
limitations is unknown. The association between activity limitations
and muscle strength might also be influenced by biomechanical
factors, such as joint proprioception. Proprioception provides the
brain with positional and motion sense through mechanoreceptors
localized within joint-capsules, muscles and tendons. Neural inputs
derived from proprioceptive sensors are hypothesized to be crucial
for the recruitment of motor units in relation to task requirements.
[23] It has been shown that proprioception of the knee is reduced
in EDS-HT patients,[24,25] however, the impact of proprioception
on the association between muscle strength and activity limitations
in EDS-HT is unknown.
Therefore, the aim of the study was to establish the association
between muscle strength and activity limitations controlled for
proprioception, pain and fatigue in EDS-HT patients.
Patients and methods
Participants
Twenty-four EDS-HT patients were recruited from the Center for
Medical Genetics at the Ghent University Hospital (Table 1).
Inclusion was based on the Villefranche criteria:[9] GJH present
(Beighton score5/9), skin hyper-extensibility, in combination with
recurring joint dislocations, pain lasting for>3 months and a posi-
tive family history. As more than 90% of the EDS-HT participants is
female,[9] the current study included only women. In addition, 24
female healthy volunteers participated. Exclusion criteria for the
control subjects were: (1) a Beighton score<4/9,[18] (2) any muscu-
loskeletal pain at present, and (3) the use of analgesics or antide-
pressants. Written informed consent was obtained from all the
participants according to the Helsinki Declaration. The study was
approved by the Medical Ethics Board of Ghent University Hospital.
Height(m) and weight(kg) were measured standardized and
Body Mass Index (BMI: kg/m2) was calculated. Skin-laxity was
determined by suction cup method [5] and expressed in retraction
force (VE: kg/cm2). Joint hypermobility was determined by the
Beighton score.[26] Disease severity, time since diagnosis, painful
body surface(%), type of complaints, medication and comorbidity,
were obtained by structured interview.
Outcome measurements
Activity limitations
Activity limitations were quantified in both capacity and perform-
ance qualifiers, according to the International Classification of
Functioning (ICF).[27,28] At the level of capacity,[29] the 30s chair-
rise test [30] (30CRT) and the six-minute walk test (6MWT) were
used.[31] At the level of performance, the Health Assessment
Questionnaire (HAQ) was used.[32]
The 30CRT was performed on a stationary chair without armr-
ests with a standardized height of 47.5 cm.[30] The participants
were instructed to rise from sitting position to complete stance,
without using the arms, as often as possible in 30s. Each success-
ful raise, defined as a complete rise from sit to stance was
recorded with a lap counter. Two trial attempts were performed.
No verbal encouragements were given.
The 6MWT was performed along an 8-m track in a straight.[31]
Participants were instructed to cover the largest possible distance
in six minutes at a self-chosen walking speed. Turns were made
on both ends of the 8-m track. Patients were encouraged every
minute in a standardized way. The outcome of the 6MWT was
expressed in meters walked and used in analyses.
The HAQ contains 20 items measuring activity limitations over
the past week in eight categories: self-care, rising, eating, walking,
hygiene, reach, grip and activities.[32] Each item was scored on a
4-point scale from 0 (no difficulty) to 3 (unable). The overall score
was calculated by summing and averaging the highest item score
of each category.[33] In order to account for the usage of assistive
devices, in agreement with standardized usage of the HAQ, a dis-
ability index was calculated and used for analysis.[33] The HAQ
disability index ranges from 0 to 3, where scores of 0 –1 represent
Table 1. Clinical characteristics.
EDS-HT Controls
Mean (SD) Range Mean (SD) Range p Values
Age (years) 41 (11) 21–57 39 (10) 24–57 p¼ 0.451
BMI (Kg/cm2) 27.8 (4.7) 20.1–37.2 22.8 (2.9) 17.9–28.6 p< 0.0001
Connective tissue laxity
Generalized joint hypermobility (Beighton score 5)c 71% (n¼ 17) – – –
Skin laxity (VE)a 3.7 2.9–4.2 4.4 3.4–5.2 p5 0.032
Activity Limitations
30s chair rise (repetitions) 10 (3) 3–18 16 (2) 12–21 p< 0.0001
6MWT (m) 358 (133) 101–525 579 (78) 462–762 p< 0.0001
HAQ (disability index: 0–3) 1.30 (.52) 0.4–2.3 0.04 (0.14) 0.0–0.63 p< 0.0001
Musculoskeletal function
Muscle strength (Normalized)b 33.7 (7.0) 23.1–47.1 42.3 (6.4) 33.6–47.1 p< 0.0001
Proprioception (angle of detection) 1.8 (1.5) 0.33–5.9 0.8 (0.4) 0.0–1.8 p50.004
Disease status
Time since diagnosis (years) 8 (8) 1–38 – – –
Total painful body surface (%) 29 (18) 4–64 – – –
Pain intensity (VAS, in mm) 65 (17) 16–95 – – –
Fatigue (CIS20 score) 62 (18) 20–98 – – –
Statistical significant differences are highlighted in bold.
aMedian score and interquartile range (P25–P75).
bNormalised over fat-free body mass.
cPercentage of subject classified with GJH.
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mild to moderate disability, 1–2 moderate to severe disability, and
2–3 severe to very severe disability.[33]
Musculoskeletal function
Muscle strength in both extremities was measured bilaterally in a
standardized way [19] with a hand-held dynamometer (Citec,
Groningen, The Netherlands). Measurements were consecutively
performed three times and the highest value was registered. In
the upper extremity, shoulder abductor and grip strength were
measured. In the lower extremity, hip flexors, knee extensors and
ankle extensors were measured. All measurements were per-
formed according to the ``break method'' with the exception of
the knee extension and grip strength. For these measurements
the ``make method'' was applied due to the inability of the asses-
sors to break the generated force of the participant.[34] Total
muscle strength was calculated by a summation of all muscles
(left and right) and normalized over fat-free body mass which was
ascertained by bio-impedance testing.[35] Normalized muscle
strength was used for the analysis (Newtons/fat-free mass).
Knee proprioception was measured according to the protocol of
Hurkmans et al.[36] This protocol has been used in healthy adults
and in osteoarthritis patients and demonstrated high inter- and
intra-reliability.[36] The device consists of a chair with a computer-
controlled motor system and two attached free-moving arms. Each
arm supports the subjects shank and foot and moves in the sagittal
plane. The joint of each arm is moved by a computer-controlled
motor and transmission system for angular displacement. The ankle
is attached with an air splint to the footrest. The measurement pro-
cedure consisted of a movement detection task. Each trial, the leg
was moved to a starting position of 30 knee flexion. Upon reach-
ing this position, movement was stopped. Following a random
delay, the knee extended further with an angular velocity of 0.3/s.
Participants were instructed to push a button at the moment of
definite detection. The angular displacement between the starting
position at 30 flexion and the position in the extension direction
at the instance when the button is pushed was recorded in degrees
as the measure of knee joint proprioception. Measures were taken
to ensure that the movement of the legs was mainly detected by
proprioceptive senses and not by visual, auditory, vibrational or
skin compression ques.[36] The angle of movement detection,
expressed in degrees, was used for the analyses.
Pain and fatigue
Pain was measured with the Visual Analog Scale (VAS) expressed in
mm, ranging from no pain (score: 0mm) to worst pain (score:
100mm). Subjects rated the average pain in the previous two
weeks.
Fatigue, perceived in the previous two weeks, was measured
by the Checklist Individual Strength (CIS). The CIS measures four
dimensions of fatigue: the subjective perception, motivation, activ-
ity, and concentration. The CIS was reported to be reliable and
valid in healthy controls and other chronic diseases.[37] The total
CIS score was calculated through summation of all the sub-items
resulting in a score ranging from 0 to 100, (no fatigue to 100 as
worst fatigue) and used for the analyses.[37]
Statistical analysis
First, descriptions of all outcomes and measures of central ten-
dency were calculated. All outcomes were centered by z-score
transformation in order to prevent collinearity. Healthy matched
controls were used within the statistical analysis as a contrast
group in order to demonstrate the divergence from normality.
Differences between the subjects were determined by independ-
ent Student t-test.
Second, the associations between dependent (activity limita-
tions) and independent variables (muscle strength, proprioception,
pain, fatigue) were estimated by Pearsons correlation coefficients.
Finally, mixed linear models were constructed for each out-
come of activity limitations. A two-level (patient/controls) structure
was used with activity limitations as the dependent and muscle
strength, proprioception the independent variables. First the asso-
ciation between the activity limitations and muscle strength was
determined (initial model). Second, proprioception was added to
the model. In the final step the association between muscle
strength and activity limitations was adjusted for pain, fatigue,
age, BMI and time since diagnosis.
In the adjusted models all independent variables were entered
stepwise. Results are presented in unstandardized regression coef-
ficients (Beta) and standard errors (SE) with 95% confidence inter-
vals (95%CI). All the statistical analyses were performed in SPSS
version 22.0. p Values< (0).05 were considered statistically
significant.
Results
Descriptives
The mean age of the population was 40 years (SD: 10, range: 21–
57). In EDS-HT patients (n¼ 24), duration of pain in years (mean
(SD)) was 24(12) and the duration of soft tissue injuries (mean
years (SD)) was 23(13). Fatigue was present in 92% of the EDS-HT
patients (mean years (SD): 14(11). Gastro-intestinal complaints
were present in 80% of the EDS-HT patients (mean years (SD): 14
(14). Time since diagnosis (mean years (SD) was 8.2(7.8). All
included EDS-HT patients fulfilled the Ville-Franche criteria (n¼ 24:
100%) and thus the diagnosis of EDS-HT was confirmed. When
regarding the main diagnostic criteria: GJH (Beighton5) was pre-
sent in 17 subjects (71%), Hyper-elastic skin was present in all the
subjects (n¼ 24: 100%). When regarding the minor criteria: in all
subjects recurring joint dislocations and chronic pain (>3 months)
were present (n¼ 24: 100%) and in 10 subjects a positive family
history was present (42%).
Differences between EDS-HT patients and controls were
observed. EDS-HT patients showed significant higher skin laxity
(DD:þ15.9%, p¼ 0.032), higher BMI (DD:þ16.5%, p<0.0001), lower
muscle strength (DD: 20.2%, p<0.0001) and poorer propriocep-
tion, in terms of higher errors in movement detection (DD: 43.6%,
p¼ 0.004). EDS-HT patients showed a significant lower score on
30CRT (DD: 59.9%, p< 0.0001), on 6MWT (DD: 61.8%,
p< 0.001) and higher HAQ disability indexes (DD:þ97.9%,
p< 0.001).
Table 2. Correlation matrix: Pearsons correlation coefficients (r).
Activity limitations
(dependent) Muscle strength Proprioception Pain Fatigue
30CRT þ0.67 0.56 0.65 0.47
6MWT þ0.58 0.41 0.70 0.47
HAQ 0.63 þ0.46 þ0.80 þ0.65
Muscle strength 0.58 0.57 0.48
Proprioception 0.58 þ0.42 þ0.33
Pain 0.57 þ0.42 þ0.62
Fatigue 0.48 þ0.33 þ0.62
p¼<0.05.Fatigue p¼<0.0001.
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Univariate analysis: correlations
Table 2 presents the correlations between activity limitations
(30CRT, 6MWT, HAQ), muscle strength and knee joint
proprioception.
Low muscle strength, was correlated with low scores on 30CRT
(r¼ 0.67, p< 0.0001), 6MWT (r¼ 0.587, p< 0.0001) and higher
HAQ scores (r¼0.63, p< 0.0001). Poor proprioception was corre-
lated with low scores on 30CRT (r¼0.56, p< 0.0001), 6MWT
(r¼0.41, p< 0.05) and high HAQ scores (r¼ 0.46, p< 0.05).
Low muscle strength was correlated with poor proprioception
(r¼0.58, p< 0.0001) pain (r¼0.57, p¼<0.0001) and fatigue
(r¼0.48, p¼<0.0001).
Multivariate analysis
Multivariate analyses are presented in Tables 3, 4, and 5 for each
outcome of activity limitation separately.
30CRT
The results of the random effects model concerning activity limita-
tions, in terms of 30CRT, are depicted in Table 3. In the initial
model (AICC: 101.48) muscle strength was associated with
increased 30CRT scores (B(SE): 0.39 (0.10), p¼<0.0001). In the
adjusted model (AICC: 100.26), proprioception was associated with
lower scores on 30CRT (B(SE): 0.23 (0.11), p¼ 0.034).
Proprioception changed the Beta of muscle strength with>10%
and confounded the association between muscle strength and
30CRT (B(SE): 0.27 (0.11), p¼ 0.017). In the final step (AICC: 97.89),
when controlling for confounders, muscle strength remained asso-
ciated with activity limitations (B(SE): 0.26 (0.10), p¼ 0.007) as did
proprioception (B(SE): 0.27(0.10), p¼ 0.028). Pain reached the
retention threshold but was not significantly associated with activ-
ity limitations according to the 30CRT (B(SE): 0.07 (0.13),
p¼ 0.199) and did not change the Beta of muscle strength
with>10%.
6MWT
The results of the random effects model concerning activity limita-
tions, in terms of 6MWT, are depicted in Table 4. In the
unadjusted model (AICC: 122.09), muscle strength was associated
with the 6MWT (B(SE): 0.28 (0.12), p¼ 0.028). The adjusted model
(AICC: 124.00) showed that proprioception did not contribute to
activity limitations, according to 6MWT (B(SE): 0.02 (0.13),
p¼ 0.756) and did not change the Beta of muscle strength with-
>10%. Proprioception did not confound the association between
muscle strength and 6MWT (B(SE): 0.27 (0.14), p> 0.200). In the
final step (AICC: 116.39), when controlling for confounders, muscle
strength remained significantly associated with activity limitations
(B(SE): 0.29 (0.13), p¼ 0.033) as did pain (B(SE): 0.63 (0.12),
p¼<0.0001) and age (B(SE): 0.24 (0.11), p¼ 0.031). No other fac-
tors were found to be significant nor were retained (p¼>0.200).
The addition of pain and age to the model with muscle strength
and proprioception did not result in a change in the Beta of
muscle strength>10%.
HAQ
The results of the random effects model concerning activity limita-
tions, in terms of HAQ, are depicted in Table 5. In the initial model
(AICC: 103.76), muscle strength was associated with HAQ (B(SE):
0.38 (0.10), p¼<0.0001). In the adjusted model (AICC: 100.35),
proprioception was found to be associated with higher activity
limitations according to HAQ (B(SE): 0.27 (0.10), p¼ 0.016).
Proprioception (B(SE): 0.24 (0.11), p¼ 0.034) did change the Beta
of muscle strength with>10%. When controlling for confounders
(AICC: 99.17), muscle strength remained associated with the HAQ
(B(SE): 0.20 (0.10), p¼ 0.049) as was proprioception (B(SE): 0.24
(0.12), p¼ 0.021). Pain (B(SE): 0.38 (0.13), p¼ 0.006) and fatigue (B
(SE): 0.25 (0.08), p¼ 0.003) were also found to be associated with
higher disability, and did change the Beta of muscle strength
with>10%.
Discussion
Muscle strength was found to be associated with activity limita-
tions in EDS-HT patients. This finding is important, despite the
prevalent use of muscle strength enhancement in clinical practice
aiming at reducing activity limitations, the scientific ground for
such rationale is lacking.[15] Proprioception confounded the asso-
ciation between muscle strength and the HAQ and the 30CRT, but
not the association between muscle strength and 6 MWT. These
results indicate that proprioception is of influence on the
Table 3. Multivariate analysis (random effects model) concerning muscle
strength and 30CRT.
30CRT
B (SE) 95% CI p Values Goodness of fit
Stage 1: initial model (unadjusted)
Muscle strength 0.39 (0.10) 0.19 0.59 <0.0001 AICC: 101.48
Stage 2: proprioception (adjusted)
Muscle strength 0.27 (0.11) 0.05 0.49 0.017 AICC: 99.45
Proprioception 0.23 (0.10) 0.44 0.02 0.034
Stage 3: Confounders (backward selection)
Muscle strength 0.26 (0.11) 0.03 0.49 0.025 AICC: 97.89
Proprioception 0.20 (0.11) 0.43 0.01 0.040
Pain 0.12 (0.14) 0.20 0.16 0.199
Table 4. Multivariate analysis (random effects model) concerning muscle
strength and 6MWT.
6MWT
B (SE) 95% CI p Values Goodness of fit
Stage 1: initial model (unadjusted)
Muscle strength 0.28 (0.12) 0.03 0.52 0.028 AICC: 122.09
Stage 2: proprioception (adjusted)
Muscle strength 0.27 (0.14) 0.01 0.58 0.053 AICC: 124.00
Proprioception 0.02 (0.14) 0.26 0.29 0.756
Stage 3: Confounders (backward selection)
Muscle strength 0.29 (0.14) 0.03 0.57 0.033 AICC: 116.74
Proprioception 0.14 (0.13) 0.12 0.41 0.286
Age 0.24 (0.11) 0.47 0.02 0.023
Pain 0.63 (0.12) 0.88 0.39 <0.0001
Table 5. Multivariate analysis (random effects model) concerning muscle
strength and HAQ.
HAQ
B (SE) 95% CI p Values Goodness of fit
Stage 1: initial model (unadjusted)
Muscle strength 0.38 (0.10) 0.59 0.18 <0.0001 AICC: 103.76
Stage 2: proprioception (adjusted)
Muscle strength 0.24 (0.11) 0.46 0.02 0.034 AICC: 100.35
Proprioception 0.27 (0.10) 0.05 0.47 0.016
Stage 3: Confounders (backward selection)
Muscle strength 0.20 (0.11) 0.42 0.02 0.049 AICC: 99.17
Proprioception 0.24 (0.10) 0.04 0.45 0.021
Pain 0.38 (0.13) 0.12 0.66 0.006
Fatigue 0.25 (0.08) 0.09 0.41 0.003
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associations between muscle strength and activity limitations, but
this influence is not consistent. These findings support evidence
for the core assumption that treatment based on muscle strength-
ening and increasing proprioception acuity might be effective [38]
in patients with EDS-HT. Although the present study provides sup-
porting evidence for the usage of muscle strength training as a
treatment modality, it also raises questions that should be
addressed before strength training can be implemented into
practice
Muscle strength in EDS-HT patients was lower than healthy con-
trols. The difference in muscle strength can be explained by the dif-
ference in connective tissue, the main clinical characteristic of EDS-
HT patients. In these patients more elastic and potentially more fra-
gile connective tissue is present, which is expressed in GJH and a
hyper-extensible skin. Previous research has shown that the pres-
ence of GJH is an independent factor associated with muscle weak-
ness, not only in subjects with symptomatic forms of GJH but also
in healthy professional dancers.[18] It can be hypothesized that
muscle weakness is not only the result of deconditioning, but is
partially caused by the inefficient force transfer through muscle
fibers due to altered structural integrity of connective tissue.[39] If
this hypothesis is true, it could have consequences for the trainabil-
ity of muscle strength in EDS-HT patients. As connective tissue stiff-
ness cannot be influenced, the effect of muscle strength training
may be limited. However, these findings were reported [18] in ado-
lescents and young adults which were more flexible compared to
the currently included population. The only influence on tissue stiff-
ness is aging. Joint mobility decreases over time as a result of aging
[40] and could also reduce the influence of connective tissue laxity
on muscle strength.
We found that poor proprioception is associated with an
increase in activity limitations. Poor proprioception has frequently
been reported in EDS-HT patients and has been postulated to be
an important factor in activity limitations.[17,24,41] Our results indi-
cate that poor proprioception, especially during activities that
require controlling discrete joint motion (knee flexion), has an influ-
ence on muscle strength. However, the generalizability to other
joints within the functional chain is unknown. Other activities like
walking are less dependent on knee flexion and therefore proprio-
ception measured at the knee could not be as important for walk-
ing as it is for rising to stance which is marked as a limitation of the
study. It has been shown that the function of proprioception is not
limited to providing the brain with coordinates of joint positions,
but also plays an important role in the coordination of muscle force
in relation to the required movements.[23] Our results might indi-
cate that proprioception is especially important for coordinating
muscle force rather than controlling joint angular momentum.
Transferring these results into clinical practice, it can be speculated
that learning to control the required muscle force is more import-
ant than just increasing raw muscle power. Possible reasons for
poor proprioception are part of discussion. One possible reason is
that proprioceptive signals are based on inadequate mechanical
forces generated from lax joint-capsules and muscle tissue.[42] In
EDS-HT patients this would result in an increased activation thresh-
old, due to altered mechanical properties of connective tissue, and
resulting in decreased proprioceptive feedback. Another possible
reason could be muscle atrophy. Muscle atrophy has been found
to result in a reduction of proprioceptive sensor density in osteo-
arthritis patients. Although a reduced sensor density has not been
demonstrated in EDS-HT, the presence of muscle atrophy has
indeed been shown in EDS-HT patients.[20] Therefore, the preven-
tion of muscle atrophy by muscle training could also protect
against poor proprioception. If connective tissue laxity and muscle
atrophy are responsible for poor proprioception, for reasons of
parsimony, this should be studied in longitudinal studies first
before implementing in clinical practice.
Pain and fatigue were found to be independently associated
with activity limitations. It is postulated that the origin of pain in
EDS-HT patients can be found in micro-fractures within joint surfa-
ces [41] and muscle structures [15] which leads to activity limita-
tions and in turn to further muscle weakness.[10] Overuse could
potentially activate nociceptive receptors which could inhibit
motor unit recruitment and further add to muscle weakness.[43]
In addition, pain and poor proprioception were also found to be
correlated. However, in multi-regression analysis, pain did not
influence the associations between activity limitations, muscle
strength and proprioception. Statistical testing did not show any
indications for multi-collinearity in terms of: univariate correlations
did not exceed>0.80, tolerances were >0.5 and the Variance
Inflation Factor (VIF) ranged from 1.6 to 2.0.[44] In combination
with the usage of centering the presence of multi-collinearity can
be excluded in all models. However, EDS-HT patients were found
to have lower pain thresholds which could also be a factor that
may lead to activity avoidance. The presence of secondary hyper-
algesia and proprioceptive inacuity could also indicate neurologic-
ally oriented mechanism that affects sensory modalities.[45]
Regarding fatigue, muscle weakness could result in additional
effort during functional activities which may in turn lead to ineffi-
cient energy consumption.
In order to correctly interpret these results, the following limi-
tations should be considered. First, the study is of cross-sectional
nature and thus no causative conclusions can be drawn nor does
it show that strength training is an effective treatment. These
results do support exploratory evidence that muscle strength is a
relevant factor in the development of activity limitations in
patients with EDS-HT. Second, EDS-HT is more frequently present
in females, therefore, only females were included in the study.
Our observations might be different in males. Finally, data on psy-
chological functioning were not incorporated in the models due
to small sample size. When considering the high prevalence of
psychological comorbidity, like anxiety, these could also have con-
siderable effects on activity limitations.
Conclusion
Muscle strength is associated with activity limitations in EDS-HT
patients. Proprioception is of influence on this association and
should be considered in the development of treatment strategies
aiming to reduce activity limitation in EDS-HT patients.
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